Compare Humana Inc (HUM) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Oxford Lane Capital Corp — how do they compare? Humana Inc trades at $403.64 (market cap $47.81B), while Oxford Lane Capital Corp trades at $8.82 (market cap $866.15M). The key difference: Humana Inc is far larger — about 55.2× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays the higher dividend (27.06%). Which is the better fit depends on your goals.
| HUM | OXLC | |
|---|---|---|
Market Cap | $47.81B | $866.15M |
Sector | Health | Financials |
52-Week High | $409.42 | $19.90 |
52-Week Low | $163.67 | $8.15 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | 27.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
OXLC trades at $8.87, up 1.14% today, but faces a bearish technical outlook with negative moving averages and oscillators. The stock shows mixed fundamentals with a low P/B of 0.83 but alarming profitability metrics including a -39.16% ROE and three consecutive quarterly EPS misses. Recent news highlights concerns over its 24% dividend yield sustainability and a sharp net asset value decline reported in May 2026.
The outlook is cautious due to deteriorating earnings, high dividend risks, and negative cash flow from operations. While the P/B ratio suggests potential undervaluation, significant headwinds from poor ROE, volatile revenue, and bearish analyst sentiment outweigh opportunities. Investors should prioritize risk management amid ongoing financial instability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
